Text this: WCN25-2926 BALANCING CARDIOVASCULAR RISK: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION IN HEMODIALYSIS PATIENTS AMID POTASSIUM CHALLENGES AND HYPOTENSION RISK